Puma Biotechnology Inc (PBYI)
3.025
+0.22
(+7.65%)
USD |
NASDAQ |
Dec 24, 12:31
Puma Biotechnology Total Liabilities (Quarterly): 149.63M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
| Oragenics Inc | 2.126M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 220.72M |
| Shareholders Equity (Quarterly) | 71.09M |
| Debt to Equity Ratio | 1.098 |
| Current Ratio | 1.420 |
| Net Debt Paydown Yield | 3.34% |